Pharmasens Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Investors
  • 1

Pharmasens General Information


Developer of user-friendly and safe devices intended to deliver insulin safely. The company designs and develops small, discreet, painless, precise and user-friendly devices integrated with continuous glucose monitoring as well as stand-alone continuous glucose monitoring systems, enabling patients to keep a track on their sugar levels in a much easier and efficient manner

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Drug Delivery
Primary Office
  • Kägenstrasse 17A
  • 4153 Reinach
  • Switzerland
+41 061 000 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pharmasens Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) Completed Generating Revenue
To view Pharmasens’s complete valuation and funding history, request access »

Pharmasens Executive Team (2)

Name Title Board Seat Contact Info
Paul Hadváry Board Member, Founder & Chief Technology Officer
Peter Diem MD Board Member & Chief Medical Officer
To view Pharmasens’s complete executive team members history, request access »

Pharmasens Board Members (4)

Name Representing Role Since
Paul Hadváry Pharmasens Board Member, Founder & Chief Technology Officer 000 0000
Peter Diem MD Pharmasens Board Member & Chief Medical Officer 000 0000
Sujay Hamlai Pharmasens Board Member 000 0000
Urs Meyer MD Pharmasens Chairman 000 0000
To view Pharmasens’s complete board members history, request access »

Pharmasens Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioBac Angel Group Minority 000 0000 000000 0
To view Pharmasens’s complete investors history, request access »